Related and Nonrelated Parties [Axis]
Related Party [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Statement Of Financial Position Location Balance [Axis]
Sweep Account [Member]
Statement Of Income Location Balance [Axis]
Patent and Licensing Related Legal and Filing Costs [Member]
Research and Development Expenses [Member]
Antidilutive Securities [Axis]
Outstanding Options to Purchase Common Stock [Member]
Warrants to Purchase Common Stock [Member]
Unvested Restricted Stock Units [Member]
Currency [Axis]
United States of America, Dollars
Australia, Dollars
Long-Lived Tangible Asset [Axis]
Lab Equipment [Member]
Finance Lease Right-of-Use Lab Equipment Net [Member]
Computer and Office Equipment [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
At-The-Market Offering Agreement [Member]
Securities Purchase Agreement [Member]
Investor Warrants [Member]
Placement Agent Warrants [Member]
Plan Name [Axis]
2015 Equity Incentive Plan [Member]
2025 Equity Incentive Plans [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Restricted Stock Units (RSUs) [Member]
NIH/NIAID Award [Member]
Phase 1b Clinical Trial [Member]
Phase 2a Clinical Trial [Member]
Income Tax Jurisdiction [Axis]
Domestic Tax Jurisdiction [Member]
State and Local Jurisdiction [Member]
Geographical [Axis]
FLORIDA
Tax Credit Carryforward [Axis]
Research Tax Credit Carryforward [Member]
AUSTRALIA
Office Space [Member]
Laboratory Space [Member]
Common Area Maintenance [Member]
Title and Position [Axis]
Dr Phillip Frost [Member]
Segments [Axis]
Segment [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Opinion [Text Block]
Auditor Name
Auditor Location
Statement of Financial Position [Abstract]
Assets
Current assets:
Cash
Restricted cash
Tax credit receivable
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Deposits
Operating lease right-of-use assets, net (including $152 and $42 to related party)
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses
Current maturities of operating lease liabilities (including $49 and $42 to related party)
Total current liabilities
Long-term liabilities:
Operating lease liabilities (including $104 and $0 to related party)
Total long-term liabilities
Total liabilities
Commitments and contingencies
Stockholders’ equity:
Common stock $0.001 par value; 100,000 and 150,000 shares authorized as of December 31, 2025 and 2024, respectively; 13,784 and 10,174 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Operating lease right of use assets related party
Operating lease liabilities related party current
Operating lease liabilities related party non-current
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income, net
Foreign exchange gain (loss)
Total other income, net
Net loss
Net loss per common share, basic
Net loss per common share, diluted
Weighted average number of common shares outstanding, basic
Weighted average number of common shares outstanding, diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Stock-based compensation
Net loss
Sale of common stock in ATM, net of transaction costs
Sale of common stock in ATM, net of transaction costs, shares
Share issuance from RSU award
Share issuance from RSU award, shares
Sale of common stock and warrants, net of transaction costs
Sale of common stock and warrants, net of transaction costs, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Right of use assets
Stock-based compensation
Change in operating lease liabilities
Changes in operating assets and liabilities:
Tax credit receivable
Prepaid expenses and other current assets
Deposits
Accounts payable and accrued expenses
Net cash used in operating activities
Investing activities:
Purchases of property and equipment
Net cash used in investing activities
Financing activities:
Proceeds from the sale of common stock under ATM
Proceeds from sale of common stock and warrants, net of transaction costs
Net cash provided by financing activities
Net decrease in cash and restricted cash
Cash and restricted cash at beginning of period
Cash and restricted cash at end of period
Supplemental disclosure:
Non-cash investing and financing activities
Initial recognition of right-of-use assets and lease liabilities
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies
Foreign Currency [Abstract]
Foreign Currency Remeasurement
Property, Plant and Equipment [Abstract]
Property and Equipment
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses
Equity [Abstract]
Common Stock
Share-Based Payment Arrangement [Abstract]
Stock Based Awards
Collaborations
Income Tax Disclosure [Abstract]
Income Taxes
Lease Commitments
Lease Commitments
Related Party Transactions [Abstract]
Transactions with Related Parties
Segment Reporting [Abstract]
Segment information
Basis of Presentation
Principles of Consolidation
Segments
Use of Estimates
Concentrations of Credit Risk
Risks and Uncertainties
Cash and Restricted Cash
Property and Equipment, net
Leases
Fair Value Measurements
Long-Lived Assets
Patent and Licensing Related Legal and Filing Costs
Research and Development Expenses
Income Taxes
Stock-Based Compensation
Common Stock Purchase Warrants and Other Derivative Financial Instruments
Net Income (Loss) per Share
Recent Accounting Pronouncements
Schedule of Reconciliation of Cash and Restricted Cash
Schedule of Anti-dilutive Securities Excluded from Calculations of Net Loss Per Share
Schedule of Cash Balance
Schedule of Property and Equipment
Schedule of Accounts Payable and Accrued Expenses
Schedule of Activity of Warrants Outstanding
Schedule of Roll-forward of Common Stock Available for Future Issuance
Schedule of Common Stock Available for Future Issuance
Schedule of Stock Option Transactions
Schedule of Restricted Stock Units
Schedule of Income (Loss) Before Provision (Benefit) for Income Taxes
Schedule of Deferred Tax Assets and Liabilities
Schedule of Reconciliation of Federal Statutory Income Tax Rate
Schedule of Components of Rent Expense and Supplemental Cash Flow Information
Schedule of Supplemental Balance Sheet Information
Schedule of Maturities of Lease Liabilities
Schedule of Segment Information
Net loss
Net cash provided by used in operating activities
Accumulated deficit
Working capital
AccountingPoliciesTable [Table]
AccountingPoliciesLineItems [Line Items]
StatementOfFinancialPositionLocationBalanceAxis [Axis]
StatementOfIncomeLocationBalanceAxis [Axis]
Cash FDIC insured amount
Cash equivalents
Warrants outstanding
General and administrative expenses
Tax credits reduction of research and development expense
Cash
Restricted cash
Total cash and restricted cash shown in the statements of cash flows
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
CashBalanceTable [Table]
CashBalanceLineItems [Line Items]
Cash Balance
Foreign exchange loss
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Total property and equipment
Less accumulated depreciation
Property and equipment, net
Depreciation expense
Accounts payable
Accrued compensation
Accrued other expenses
Total accounts payable and accrued expenses
Shares Underlying Warrants Outstanding, Beginning balance
Weighted Average Exercise Price Outstanding, Beginning balance
Aggregate Intrinsic Value, Beginning balance
Shares Underlying Warrants, Granted
Weighted Average Exercise Price, Granted
Shares Underlying Warrants, Exercised
Weighted Average Exercise Price, Exercised
Shares Underlying Warrants, Expired
Weighted Average Exercise Price, Expired
Shares Underlying Warrants Outstanding, Ending balance
Weighted Average Exercise Price Outstanding, Ending balance
Aggregate Intrinsic Value, Beginning balance
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Capital stock, shares authorized
Preferred stock, shares authorized
Common stock, voting rights
Value of shares available for sale
Number of shares sold
Average share price
Net proceeds of common stock
Unit price per share
Warrants exercise price
Warrant expiration period
Gross proceeds
Share per price
Warrant issued to purchase of common stock
Fee payment description
Proceeds from sale of common shares and warrants
Shares Available for Grant, Beginning balance
2015 Plan expiration
2025 Plan addition
Shares Available for Grant, Ending balance
Stock options issued and outstanding
Restricted stock units issued and outstanding
Shares authorized for future option grants
Warrants outstanding
Total
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Options Outstanding, Beginning balance
Weighted Average Exercise Price, Beginning balance
Aggregate Intrinsic Value, Beginning balance
Total Options Outstanding, Exercised
Weighted Average Exercise Price, Exercised
Total Options Outstanding, Granted
Weighted Average Exercise Price, Granted
Total Options Outstanding, Cancelled
Weighted Average Exercise Price, Cancelled
Total Options Outstanding, Ending balance
Weighted Average Exercise Price, Ending balance
Aggregate Intrinsic Value, Ending balance
Total Restricted Stock Units Outstanding, Beginning balance
Weighted Average Fair Value, Beginning balance
Aggregate Intrinsic Value, Beginning balance
Total Restricted Stock Units Outstanding, Exercised
Weighted Average Fair Value, Exercised
Total Restricted Stock Units Outstanding, Forfeited
Weighted Average Fair Value, Forfeited
Total Restricted Stock Units Outstanding, Vested
Weighted Average Fair Value, Vested
Total Restricted Stock Units Outstanding, Ending balance
Weighted Average Fair Value, Ending balance
Aggregate Intrinsic Value, Ending balance
Number of shares authorized for issuance
Maximum term of options granted
Number of shares available for grant
Common stock outstanding, percentage
Number of additional shares issued
Options outstanding
Weighted average exercise price of options outstanding
Weighted average remaining contractual term of options outstanding
Options vested and exercisable
Weighted average exercise price of options vested and exercisable
Weighted averageremaining contractual term of options vested and exercisable
Aggregate intrinsic value of outstanding and exercisable options
Fair value of restricted stock unit
Equity-based compensation expense
Unrecognized compensation expense
Weighted average period for recognition
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Award amount received
Estimated agreement cost
Expense amount
Accrued expense
Prepaid reservation fee
Domestic
Foreign
Worldwide income
Deferred tax assets:
Net operating loss carryforwards
Compensation
Research and development tax credits
Capitalized and Research Expenditures
Other
Total deferred tax assets
Deferred tax liabilities:
Property and equipment
Other
Total deferred tax liabilities
Total deferred taxes, net
Valuation allowance
Deferred tax liability, net
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory federal income tax rate, amount
Statutory federal income tax rate
State tax, net of federal income tax effect
R&D Refund, amount
R&D Refund
Nondeductible research expenditures, amount
Nondeductible research expenditures
Foreign tax effects, Other, amount
Foreign tax effects, Other
Effects of changes in tax laws or rates enacted in the current period
Effects of cross-border tax laws
Research credits, amount
Research credits
Change in valuation allowance, amount
Change in valuation allowance
Nontaxable or nondeductible items, Other, amount
Nontaxable or nondeductible items, Other
Equity compensation, amount
Equity compensation
Other tax, credit and adjustments
Changes in Unrecognized Tax Benefits
Foreign rate differential
Effective income tax rate
Operating loss carryforwards
Operating loss carryforwards not subject to expiration
Operating loss carryforwards expiration
Tax credit carry forward
LeasesTable [Table]
Lease expiration date
Operating lease, weighted average discount rate
Operating lease, weighted average remaining lease term
Operating lease, renewal term
Payment lease cost
Debt discount rate
Operating expenses
Operating lease expense
Schedule Of Components Of Rent Expense And Supplemental Cash Flow Information
Operating lease cost (included in operating expenses in the Company’s consolidated statements of operations)
Cash paid for amounts included in the measurement of lease liabilities
Weighted average remaining lease term - operating leases (in years)
Average discount rate – operating leases
Schedule Of Supplemental Balance Sheet Information
Long-term right-of-use assets of which $102 and $152 relates to related party, respectively, net of accumulated amortization of $570 and $266, respectively
Short-term operating lease liabilities, of which $56 and $49 relates to related party, respectively
Long-term operating lease liabilities, of which $47 and $104 relates to related party, respectively
Total operating lease liabilities
Related party, Long-term right-of-use assets
Operating lease right-of-use assets amortization expenses
Related party, Short-term operating lease liabilities
Related party, Long-term operating lease liabilities
2026
2027
2028
2029
2030 and thereafter
Total minimum operating lease payments
Less: present value discount
Total operating lease liabilities
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Rent expense
Discount rate
Lease deposit paid
Rent and other expenses
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Revenue
Salaries and personnel costs
Insurance
Other operating expenses
Other income
Number of reporting segments
Number of operating segments
At-The-Market Offering Agreement [Member]
Securities Purchase Agreement [Member]
Investor Warrants [Member]
Placement Agent Warrants [Member]
Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price.
Share based compensation arrangement by share based payment award non-option equity instruments grants in period weighted average exercise price.
Share based compensation arrangement by share based payment award non-option equity instruments exercises in period weighted average exercise price.
Share based compensation arrangement by share based payment award non-option equity instruments expirations in period weighted average exercise price.
Share based compensation arrangement by share based payment award non-option equity instruments outstanding intrinsic value.
2015 Equity Incentive Plan [Member]
2025 Equity Incentive Plans [Member]
Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]
Share based payment arrangement, plan additions.
Share based compensation arrangement by share based payment award options exercisable aggregate intrinsic value.
Tabular disclosure of common stock available for future issuance.
Share based compensation arrangement by share based payment award equity instruments other than options grants in period total fair value.
Share based compensation arrangement by share based payment award equity instruments other than options exercised in period.
Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value.
Prepaid resevation fee.
Phase 2a Clinical Trial [Member]
Estimated agreement cost.
Phase 1b Clinical Trial [Member]
Right of use assets related to lease expenses.
Change in operating lease liabilities.
NIH/NIAID Award [Member]
Initial recognition of right of use assets and lease liabilities.
Deferred tax assets capitalized and research expenditures.
Working capital.
Sweep Account [Member]
Risks And Uncertainties [PolicyTextBlock]
Patent And Licensing Related Legal And Filing Costs [PolicyTextBlock]
Patent and Licensing Related Legal and Filing Costs [Member]
Income tax reconciliation foreign income tax rate other.
Effective income tax rate reconciliation foreign income tax rate other.
Office Space [Member]
Laboratory Space [Member]
Outstanding Options to Purchase Common Stock [Member]
Warrants to Purchase Common Stock [Member]
Unvested Restricted Stock Units [Member]
Statement of Financial Position Location Balance [Axis]
Statement of Income Location Balance [Axis]
Operating lease right of use asset accumulated amortization.
Lessee operating lease liability payments due year five and thereafter.
Effective income tax rate reconciliation at federal statutory income tax rates.
Related party operating lease liabilities current.
Related party operating lease liabilities non-current.
Related party operating lease right-of-use asset.
Common Area Maintenance [Member]
Dr Phillip Frost [Member]
Segment [Member]
Income tax reconciliation income tax expense benefit at federal statutory income tax rates.
Research and Development Expenses [Member]
Lab Equipment [Member]
Finance Lease Right-of-Use Lab Equipment Net [Member]
Computer and Office Equipment [Member]
Assets, Current
Assets [Default Label]
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Income (Loss)
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Shares, Outstanding
Share-Based Payment Arrangement, Noncash Expense
ChangeInOperatingLeaseLiabilities
Increase (Decrease) in Income Taxes Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Deposit Assets
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Lessee, Operating Leases [Text Block]
Income Tax, Policy [Policy Text Block]
Cash and Cash Equivalent
Restricted Cash and Cash Equivalent, Current
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrinsicValue
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Common Stock, Capital Shares Reserved for Future Issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Deferred Tax Assets, Gross
Deferred Tax Liabilities, Property, Plant and Equipment
Deferred Tax Liabilities, Other
Deferred Tax Liabilities, Gross
Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Valuation Allowance
Deferred Tax Liabilities, Net
Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount